Financial highlights · Group revenue amounted to 10,374 TSEK, 1,068 KUSD, an increase of 1 percent over the same period 2018. · Year to date Group revenue was 32,484 TSEK, 3,446 KUSD, an increase of 28 percent over the same period 2018. Business highlights · Following FDA clearance, the first DigniCap Delta contract in the U.S. was signed with large healthcare provider Atrium Health. · University of California, San Francisco (UCSF) received the first U.S. installation of DigniCap Delta. · Dignitana secured funding of SEK 42 million in a directed new issue of units in order to a accelerate growth plans and global roll out of new DigniCap Delta. · The Therapeutic Goods Administration approved DigniCap Delta for sales in Australia. Significant events after the reporting period · Dignitana signed a new distributor, AMI Medical Technologies in Israel, as well as a contract for the sale of the first DigniCap Delta devices in the country. · Dignitana sold the first DigniCap Delta units in Australia through longtime distribution partner Aurora BioScience. · A master contract was signed with a large U.S. healthcare provider to place DigniCap Delta in up to 11 locations in the Midwest region. · Start of fourth quarter shows strong demand. Dignitana Group Q3  Q3 Q1-Q3  Q1-Q3 Full year 2018 2019  2018 2019 2018 Net Revenue, TSEK 9 945 10166 31 127  25 039 33 742 Total Revenue, TSEK 10 374 10 293 32 484 25 303 34 075 Net profit after (10  (6 (22 (20 (25 846) financial items, TSEK 146) 349) 890) 651) Cash and bank balances, 40 518 4 562 40 518 4 562 22 161 TSEK Earnings per share  (0,21) (0,16)   (0,48)  (0,51) -0,66 before and after dilution, SEK                         Dignitana AB Q3  Q3 Q1-Q3  Q1-Q3 Full year 2018 2019  2018 2019 2018 Net Revenue, TSEK 6 166 6 810 20 741 18 537 24 849 Total Revenue, TSEK 6 596 6 937 22 098 18 800 25 392 Net profit after (6 104)  (5 (14 (19 (25 796) financial items, TSEK 975) 252) 933) Cash and bank balances, 39 172 3 645  39 172 3 645 19 519 TSEK The full report is attached to this release and will be posted today at https://dignitana.com/investor-relations/financial-reports/ This information is information that Dignitana AB is obliged to make public pursuant to the EU Market Abuse Regulation. The information was submitted for publication, by the above contact, for publication at 0830 CET on 22 August 2019.